greeksoup/ stock research
Stock research / United States / JNJ / Q4 FY2021

Johnson & Johnson (JNJ) Q4 FY2021 earnings: revenue $24.8 billion, up 10.4% on the year

Johnson & Johnson (JNJ) reported revenue of $24.8 billion for Q4 FY2021, the quarter ended 2 January 2022, up 10.4% on the same quarter a year earlier. Net income was $4.7 billion, up 172.5% on the year, and diluted earnings per share $1.77. The figures are the company's own, from the 10-K it filed with the SEC on 17 February 2022.

Revenue
$24.8 billion
+10.4% on the year · +6.3% on the quarter
Q1 FY2020Q4 FY2021
Operating margin
n/a
Q1 FY2020Q4 FY2021
Net income
$4.7 billion
+172.5% on the year · +29.2% on the quarter
Q1 FY2020Q4 FY2021
Diluted EPS
$1.77
+172.3% on the year · +29.2% on the quarter
Q1 FY2020Q4 FY2021

this quarterthe same quarter a year earlierHover a bar for its figure.

Income statement (profit and loss)

$ millionQ4 FY2021Q3 FY2021Q4 FY2020On the quarterOn the yearLast 8 quarters
Revenue24,80423,33822,475+6.3%+10.4%
Cost of revenue7,955n/an/a
Gross profit16,849n/an/a
Gross margin67.9%n/an/a
Research and development4,720n/an/a
Selling, general and administrative7,154n/an/a
Interest expense60.0n/an/a
Pre-tax income4,836n/an/a
Income tax100n/an/a
Effective tax rate2.1%n/an/a
Net income4,7363,6671,738+29.2%+172.5%
Net margin19.1%n/an/a
Diluted EPS$1.77$1.37$0.65+29.2%+172.3%
$ million except per share.
Read moreFourth quarters are the year less the first three quarters. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionQ4 FY2021Q3 FY2021Q4 FY2020On the quarterOn the yearLast 8 quarters
Operating cash flow5,732n/an/a
Capital expenditure1,415n/an/a
Free cash flow4,317n/an/a
Free cash flow margin17.4%n/an/a
Cash from investing-5,360n/an/a
Cash from financing-3,436n/an/a
Depreciation and amortisation1,8431,8141,940+1.6%-5.0%
Share-based compensation215n/an/a
Buybacks996n/an/a
Dividends paid2,791n/an/a
Diluted shares, weighted2,670m2,675m2,671m-0.2%-0.0%
Shares outstanding at period end2,629m2,633m2,629m-0.1%+0.0%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet

$ millionQ4 FY2021Q3 FY2021Q4 FY2020On the quarterOn the yearLast 8 quarters
Shareholders' equity74,02370,27263,278+5.3%+17.0%
Debt33,75133,92835,266-0.5%-4.3%
Other liabilities74,244n/an/a
Total liabilities and equity182,018n/an/a
Fixed assets18,962n/an/a
Goodwill35,246n/an/a
Intangible assets46,392n/an/a
Investments17,121n/an/a
Cash and equivalents14,48717,60413,985-17.7%+3.6%
Receivables15,283n/an/a
Inventory10,387n/an/a
Other assets24,140n/an/a
Total assets182,018n/an/a

Questions

What was Johnson & Johnson's revenue in Q4 FY2021?

Johnson & Johnson (JNJ) reported revenue of $24.8 billion for Q4 FY2021, the quarter ended 2 January 2022, up 10.4% on the same quarter a year earlier.

How much did Johnson & Johnson earn in Q4 FY2021?

Net income for Q4 FY2021 was $4.7 billion, up 172.5% on the year, and diluted earnings per share $1.77.

When did Johnson & Johnson report Q4 FY2021 results?

Johnson & Johnson filed its 10-K for the year that ended with the quarter on 17 February 2022; the fourth quarter is the year less the first three.

Quarterly results, the last 20 quarters

Q4 FY2021 *Q1 FY2022 †Q2 FY2022 †Q3 FY2022 †Q4 FY2022Q1 FY2023 †Q2 FY2023 †Q3 FY2023Q4 FY2023 †Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue24,80419,84020,21519,99619,93920,89421,51921,35121,39521,38322,44722,47122,52021,89323,74323,99324,56424,06225,31025,399
Cost of revenue7,9557,5987,9196,1727,7656,6876,4626,6066,7986,5116,8696,9637,1287,3577,6287,3037,9688,1068,0518,097
Gross profit16,84913,82213,89313,82413,85514,20715,05714,74514,59714,87215,57815,50815,39214,53616,11516,69016,59615,95617,25917,302
Gross margin68%70%69%69%69%68%70%69%68%70%69%69%68%66%68%70%68%66%68%68%
R&D4,7203,4623,7033,4853,8413,4553,7033,4474,2463,5423,4404,9525,2983,2253,5163,6724,2523,5273,6534,652
SG&A7,1545,9386,2264,9756,5124,9065,3965,4005,8105,2575,6815,4786,4535,1125,8895,9226,7536,0346,4326,285
Interest expense60.010.038.051.017721234619219.0155270193137204308245214272281217
Pre-tax income4,8365,2035,1445,1723,840-1,2876,3065,2174,8263,7145,7483,3383,88713,6316,4917,4934,9665,9906,74734.0
Tax rate2%14%20%17%18%n/a15%17%14%12%18%19%12%19%15%31%-3%13%18%-518%
Net income4,7365,1494,8144,4583,520-68.05,14426,0284,0493,2554,6862,6943,43110,9995,5375,1525,1165,2355,534210
Net margin19%26%24%22%18%-0%24%122%19%15%21%12%15%50%23%21%21%22%22%1%
Diluted EPS$1.77$1.93$1.80$1.68$1.33-$0.03$1.96$10.21$1.67$1.34$1.93$1.11$1.41$4.54$2.29$2.12$2.10$2.14$2.27$0.09
Operating cash flow5,7323,9795,5816,2845,3503,2574,1827,4897,8633,6575,6337,9936,9834,1743,8789,1697,3092,5148,6167,720
Capital expenditure1,4156078639521,5878631,1249671,5898079761,0291,6127951,0431,1571,8371,0491,3211,362
Free cash flow4,3173,3724,7185,3323,7632,3943,0586,5226,2742,8504,6576,9645,3713,3792,8358,0125,4721,4657,2956,358
Buybacks9961,5779732,1651,3203,5373819202161,4751365392822,1270.01,9021,9244,0282211,709
Dividends paid2,7912,7872,9712,9702,9542,9423,0922,8712,8652,8692,9852,9852,9842,9893,1293,1323,1313,1313,2273,227
Shares outstanding2,629m2,631m2,629m2,614m2,409m2,599m2,599m2,407m2,409m2,407m2,407m2,408m2,408m2,406m2,408m2,409m2,410m2,407m2,410m2,407m
Filing10-K10-K10-K10-Q10-K10-K10-K10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

10-K for the period ended 2 January 2022, filed 17 February 2022: the filing.